Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1968 2
1971 1
1972 3
1973 1
1974 4
1975 1
1976 2
1977 1
1978 3
1979 4
1980 1
1981 1
1982 3
1983 5
1984 6
1985 6
1986 2
1987 9
1988 3
1989 10
1990 10
1991 17
1992 13
1993 23
1994 24
1995 12
1996 23
1997 14
1998 30
1999 48
2000 42
2001 88
2002 98
2003 123
2004 188
2005 209
2006 246
2007 322
2008 370
2009 456
2010 525
2011 588
2012 693
2013 794
2014 795
2015 863
2016 878
2017 869
2018 888
2019 871
2020 915
2021 989
2022 924
2023 865
2024 882
2025 745

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,747 results

Results by year

Filters applied: . Clear all
Page 1
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallée PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touzé E, Varenne O, Vicaut É, Yelles N, Bruckert E; Treat Stroke to Target Investigators. Amarenco P, et al. Among authors: kim yj. N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18. N Engl J Med. 2020. PMID: 31738483 Clinical Trial.
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
Yang JC, Lu S, Hayashi H, Felip E, Spira AI, Girard N, Kim YJ, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Passaro A, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Kim SW, Gadgeel SM, Owen S, Xie J, Sun T, Mehta J, Venkatasubramanian R, Ennis M, Fennema E, Daksh M, Roshak A, Man J, Knoblauch RE, Bauml JM, Baig M, Shah S, Sethi S, Cho BC; MARIPOSA Investigators. Yang JC, et al. Among authors: kim yj. N Engl J Med. 2025 Sep 7. doi: 10.1056/NEJMoa2503001. Online ahead of print. N Engl J Med. 2025. PMID: 40923797
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Brüggemann N, Borsche M, Foroud T, Tolosa E, Garrido A, Annesi G, Gagliardi M, Bozi M, Stefanis L, Ferreira JJ, Correia Guedes L, Avenali M, Petrucci S, Clark L, Fedotova EY, Abramycheva NY, Alvarez V, Menéndez-González M, Jesús Maestre S, Gómez-Garre P, Mir P, Belin AC, Ran C, Lin CH, Kuo MC, Crosiers D, Wszolek ZK, Ross OA, Jankovic J, Nishioka K, Funayama M, Clarimon J, Williams-Gray CH, Camacho M, Cornejo-Olivas M, Torres-Ramirez L, Wu YR, Lee-Chen GJ, Morgadinho A, Pulkes T, Termsarasab P, Berg D, Kuhlenbäumer G, Kühn AA, Borngräber F, de Michele G, De Rosa A, Zimprich A, Puschmann A, Mellick GD, Dorszewska J, Carr J, Ferese R, Gambardella S, Chase B, Markopoulou K, Satake W, Toda T, Rossi M, Merello M, Lynch T, Olszewska DA, Lim SY, Ahmad-Annuar A, Tan AH, Al-Mubarak B, Hanagasi H, Koziorowski D, Ertan S, Genç G, de Carvalho Aguiar P, Barkhuizen M, Pimentel MMG, Saunders-Pullman R, van de Warrenburg B, Bressman S, Toft M, Appel-Cresswell S, Lang AE, Skorvanek M, Boon AJW, Krüger R, Sammler EM, Tumas V, … See abstract for full author list ➔ Vollstedt EJ, et al. Among authors: kim yj. Mov Disord. 2023 Feb;38(2):286-303. doi: 10.1002/mds.29288. Epub 2023 Jan 24. Mov Disord. 2023. PMID: 36692014 Free article.
Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial.
Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GR; Explore the Efficacy and Safety of Edoxaban in Patients after Heart Valve Repair or Bioprosthetic Valve Replacement (ENAVLE) study group. Shim CY, et al. Among authors: kim yj. J Thorac Cardiovasc Surg. 2023 Jan;165(1):58-67.e4. doi: 10.1016/j.jtcvs.2021.01.127. Epub 2021 Feb 9. J Thorac Cardiovasc Surg. 2023. PMID: 33726903 Free article. Clinical Trial.
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes.
Rodriguez-Sevilla JJ, Ganan-Gomez I, Kumar B, Thongon N, Ma F, Chien KS, Kim YJ, Yang H, Loghavi S, Tan R, Adema V, Li Z, Tanaka T, Uryu H, Kanagal-Shamanna R, Al-Atrash G, Bejar R, Banerjee PP, Lynn Cha S, Montalban-Bravo G, Dougherty M, Fernandez Laurita MC, Wheeler N, Jia B, Papapetrou EP, Izzo F, Dueñas DE, McAllen S, Gu Y, Todisco G, Ficara F, Della Porta MG, Jain A, Takahashi K, Clise-Dwyer K, Halene S, Bertilaccio MTS, Garcia-Manero G, Daher M, Colla S. Rodriguez-Sevilla JJ, et al. Among authors: kim yj. Nat Commun. 2025 Apr 11;16(1):3450. doi: 10.1038/s41467-025-58662-0. Nat Commun. 2025. PMID: 40216768 Free PMC article.
Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA.
Lee SH, Lu S, Hayashi H, Felip E, Spira AI, Girard N, Kim YJ, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Dias JM, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Chih-Hsin Yang J, Besse B, Thomas M, Shah S, Baig M, Curtin JC, Zhang J, Xie J, Sun T, Sethi S, Wang M, Fennema E, Daksh M, Ennis M, Bauml JM, Cho BC. Lee SH, et al. Among authors: kim yj. J Thorac Oncol. 2025 Jul 3:S1556-0864(25)00821-4. doi: 10.1016/j.jtho.2025.06.030. Online ahead of print. J Thorac Oncol. 2025. PMID: 40617394 Free article.
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).
Yang JC, Wang M, Doucet L, Fan Y, Lv D, Sun M, Huang D, Greillier L, Planchard D, Hong Q, Mazieres J, Felip E, Li X, Hu Y, Fang J, Bazhenova L, Ghiringhelli F, Cobo Dols MA, Rodriguez LP, Bearz A, Pellini B, Kim YJ, Bosch-Barrera J, Shim BY, Luo YH, Tiseo M, Yang TY, Carcereny E, Memmott RM, Zalcman G, de Castro Carpeno J, Di Noia V, Parra HS, Streich G, Lee DH, Shum E, Han JY, Jaime JC, Brungs D, John T, D'Arcangelo M, Joaquin AB, Liu G, Antonuzzo L, Hinojal GF, Le X, Zheng L, Jänne PA; WU-KONG1B. Yang JC, et al. Among authors: kim yj. J Clin Oncol. 2025 Oct 10;43(29):3198-3208. doi: 10.1200/JCO-25-00788. Epub 2025 Sep 9. J Clin Oncol. 2025. PMID: 40923280 Clinical Trial.
Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021.
GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com; Wijeratne T, Oh J, Kim S, Yim Y, Kim MS, Shin JI, Oh YS, Jung R, Kim YS, Smith L, Aalruz H, Abd-Rabu R, Abdulah DM, Aboagye RG, Abolmaali M, Abtahi D, Abualhasan A, Adedoyin RA, Adnani QES, Afrashteh F, Aggarwal N, Ahmad D, Ahmadi A, Ahmadi NS, Ahmadzade AM, Ahmed SA, Al Awaidy S, Alabbad S, Alajlani MM, Al-Ajlouni Y, Ali MU, Ali SS, Ali W, Almazan JU, Alshahrani NZ, Altaf A, Al-Wardat M, Alzoubi KH, Amiri S, Amu H, Amusa GA, Anderson DB, Anwar S, Areda D, Asghari-Jafarabadi M, Ashina S, Ashraf J, Ashraf T, Azargoonjahromi A, Bahurupi Y, Baig AA, Bandyopadhyay S, Bardhan M, Barqawi HJ, Bashiri A, Bastan MM, Bemanalizadeh M, Bensenor IM, Berhie AYY, Bhagavathula AS, Bhaskar S, Bhat V, Bhatti GK, Bhatti JS, Bilgin C, Biswas A, Bizzozero-Peroni B, Bustanji Y, Cámera LA, Caronna E, Carvalho AF, Chakraborty S, Ching PR, Christodoulou N, Chu DT, Chu H, Cruz-Martins N, Dadras O, Dai X, D'Amico E, Darwish AH, Deekonda S, Devanbu VGC, Dharmaratne SD, Dima A, Dinkayehu TE, Do H, Doku PN, Doshi OP, E'mar AR, Eissazade N, Eltaha C, Fahim A, Fares J, Farjoud Kouhanjani M, Faro A, Fazeli P, Fereshtehnejad SM, Ferrara P, Fe… See abstract for full author list ➔ GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com, et al. Among authors: kim yj. Cell Rep Med. 2025 Oct 21;6(10):102348. doi: 10.1016/j.xcrm.2025.102348. Epub 2025 Sep 18. Cell Rep Med. 2025. PMID: 40972580
Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma Biomarkers.
Kang SH, Lee EH, Kim YJ, Jang H, Shin D, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton NJ, Yun J, Kim HJ, Na DL, Kim JP, Seo SW. Kang SH, et al. Among authors: kim yj. JAMA Netw Open. 2025 May 1;8(5):e258842. doi: 10.1001/jamanetworkopen.2025.8842. JAMA Netw Open. 2025. PMID: 40343697 Free PMC article.
13,747 results
You have reached the last available page of results. Please see the User Guide for more information.